The Solomon Group research interests are in the area of soft matter – materials with properties intermediate between fluids and solids. The Solomon group has developed and applied 3D confocal microscopy, rheological, and light scattering methods to study the soft matter phenomena of self-assembly, gelation, and the biomechanics of bacterial biofilms.

Schwendeman’s principal research interest is to understand how phospholipid composition of high-density lipoprotein (HDL) affects its potency and to design short synthetic peptides that mimic various functions of Apolipoprotein A-I, the main HDL protein. Laboratory work focuses on HDL for treatment of sepsis, Alzheimer’s disease, complications of diabetes, lupus and other autoimmune diseases and using synthetic HDL nanoparticles for targeted drug delivery purposes and designing artificial HDL based on gold nanoparticles.

Research in the Kotov Group focuses on self-organization of nanocolloids, layer-by-layer assembly, ultrastrong nanocomposites, tissue engineering with nanomaterials, nanoscale drugs, and implantable biomedical devices.

Research Interest: Affinity Ligand Drug Targeting

Glotzer’s research on computational assembly science and engineering aims toward predictive materials design of colloidal and soft matter, with current emphasis on shape, packing, and assembly pathways.

The VanEpps laboratory focuses on life-threatening infections, particularly those associated with implanted medical devices. His research addresses the biophysical processes of bacterial cell-cell interaction, bacterial interactions with abiotic surfaces, and biofilm development. The overarching goal of his team is to translate novel technologies aimed at the detection of subclinical medical device related infection, prevention of bacterial adhesion and colonization of devices, and in situ treatment of established biofilms for device salvage strategies.

Dr. Lee and the Bioplasmonics Group focuses on advancing innovations utilizing nanoscale-dependent properties to enable unique spatial and temporal capabilities needed for quantification in bioscience and medicine. Areas of expertise include plasmonics, nanophotonics, and bionanotechnologies.

The Larson Group’s research interests include the structure and flow properties of viscous or elastic fluids, sometimes called “complex fluids,” which include polymers, colloids, surfactant-containing fluids, liquid crystals, and biological macromolecules such as DNA, proteins, and lipid membranes. The Larson group applies these concepts to drug release materials, coating materials, personal care products, and other applications of advanced materials.

The Tessier lab aims to develop next generation technologies for designing, discovering, engineering, characterizing, formulating and delivering biologics ranging from small affinity peptides to large monoclonal antibodies for molecular imaging, diagnostic and therapeutic applications.